Acute otitis media: Management and surveillance in an era of pneumococcal resistance - A report from the drug-resistant Streptococcus pneumoniae therapeutic working group

Pediatric Infectious Disease Journal

Volumn 18, Issue 1, 1999, Pages 1-9

  Dowell, Scott F ^a   Butler, Jay C ^b   Giebink, G Scott ^b   Jacobs, Michael R ^b   Jernigan, Daniel ^b   Musher, Daniel M ^b   Rakowsky, Alexander ^b   Schwartz, Benjamin ^b  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b NONE

Author keywords

Acute otitis media; Antimicrobial resistance; Streptococcus pneumoniae; Surveillance; Therapeutics

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; CEFACLOR; CEFIXIME; CEFPODOXIME; CEFPROZIL; CEFTIBUTEN; CEFTRIAXONE; CEFUROXIME; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; LORACARBEF;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MINIMUM INHIBITORY CONCENTRATION; ORAL DRUG ADMINISTRATION; OTITIS MEDIA; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; STREPTOCOCCUS PNEUMONIAE;

EID: 0032955872     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199901000-00002     Document Type: Review

References (59)

1. Barnett ED, Klein JO. The problem of resistant bacteria for the management of acute otitis media. Pediatr Clin North Am 1995;42:509-17.
2. Poole MD. Otitis media complications and treatment failures: implications of pneumococcal resistance. Pediatr Infect Dis J 1995;14:S23-6.
3. Jacobs MR. Increasing importance of antibiotic-resistant Streptococcus pneumoniae in acute otitis media. Pediatr Infect Dis J 1996;15:940-3.
4. Dagan R, Abramson O, Leibovitz E, et al. Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin. Pediatr Infect Dis J 1996;15:980-5.
5. Gehanno P, Lenoir G, Berche P. In vivo correlates for Streptococcus pneumoniae penicillin resistance in acute otitis media. Antimicrob Agents Chemother 1995;39:271-2.
6. Dagan R, Abramson O, Leibovitz E, et al. Bacteriologic response to oral cephalosporins: are established susceptibility breakpoints appropriate in the case of acute otitis media? J Infect Dis 1997;176:1253-9.
7. del Castillo F, Baquero-Artigao F, Garcia-Perea A. Influence of recent antibiotic therapy on antimicrobial resistance of Streptococcus pneumoniae in children with acute otitis media in Spain. Pediatr Infect Dis J 1998;17:94-7.
8. Cetron MS, Breiman RF, Jorgensen JH, Schuchat A, Deaver-Robinson KA, Kolcak MS. Geographic variation of drug-resistant Streptococcus pneumoniae (DRSP) [Abstract C-371]. Abstracts of the 97th General Meeting of the American Society for Microbiology, Miami Beach, 1997. Washington, DC: American Society for Microbiology, 1997:185.
9. Thornsberry C, Ogilvie P, Kahn J, Mauriz Y. Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. Diag Microbiol Infect Dis 1997;29:249-57.
10. Goldstein FW, Acar JF. Antimicrobial resistance among lower respiratory tract isolates of Streptococcus pneumoniae: results of a 1992-93 western Europe and USA collaborative surveillance study. The Alexander Project Collaborative Group. J Antimicrob Chemother 1996;38(Suppl A):71-84.
11. MMWR. Assessment of national reporting of drug-resistant Streptococcus pneumoniae: United States, 1995-1996. MMWR 1996;45:947-9.
12. Craig WA, Andes D. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatr Infect Dis J 1996;15: 255-9.
13. Krause PJ, Owens NJ, Nightingale CH, Klimek JJ, Lehmann WB, Quintiliani R. Penetration of amoxicillin, cefaclor, erythromycin-sulfisoxazole, and trimethoprim-sulfamethoxazole into the middle ear fluid of patients with chronic serous otitis media. J Infect Dis 1982;145:815-21.
14. Dowell SF, Schwartz B. Resistant pneumococci: protecting patients through judicious use of antibiotics. Am Fam Physician 1997;55:1647-54.
15. Seikel K, Shelton S, McCracken GH. Middle ear fluid concentrations of amoxicillin after large dosages in children with acute otitis media. Pediatr Infect Dis J 1997;16:710-1.
16. Burch D, McCracken G, Moonsammy G. Clinical profile of amoxicillin/clavulanate for the treatment of acute otitis media [Abstract 373]. Abstracts of the 35th Annual Meeting, Infectious Diseases Society of America, San Francisco, September 13 to 16, 1997:140.
17. Block SL, Harrison CJ, Hedrick JA, et al. Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management. Pediatr Infect Dis J 1995;14:751-9.
18. van Dyk JC, Terespolsky SA, Meyer CS, van Niekerk CH, Klugman KP. Penetration of cefpodoxime into middle ear fluid in pediatric patients with acute otitis media. Pediatr Infect Dis J 1997;16:79-81.
19. Doern GV, Brueggemann A, Holley HP Jr, Rauch AM. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob Agents Chemother 1996;40: 1208-13.
20. Appelbaum PC. Epidemiology and in vitro susceptibility of drug-resistant Streptococcus pneumoniae. Pediatr Infect Dis J 1996;15:932-4.
21. Nelson CT, Mason EO Jr, Kaplan SL. Activity of oral antibiotics in middle ear and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: implications for treatment. Pediatr Infect Dis J 1994;13:585-9.
22. Klimek JJ, Nightingale C, Lehmann WB, Quintiliani R. Comparison of concentrations of amoxicillin and ampicillin in serum and middle ear fluid of children with chronic otitis media. J Infect Dis 1977;135:999-1002.
23. Ginsburg CM, McCracken GH Jr, Nelson JD. Pharmacology of oral antibiotics used for treatment of otitis media and tonsillopharyngitis in infants and children. Ann Otol Rhinol Laryngol Suppl 1981;90:37-43.
24. Friedland IR, McCracken GH Jr. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med 1994;331:377-82.
25. Canafax DM, Yuan Z, Chonmaitree T, Deka K, Russlie HQ, Giebink GS. Amoxicillin middle ear fluid penetration and pharmacokinetics in children with acute otitis media. Pediatr Infect Dis J 1998;17:149-56.
26. Lister PD, Pong A, Chartrand SA, Sanders CC. Rationale behind high-dose amoxicillin therapy for acute otitis media due to penicillin-nonsusceptible pneumococci: support from in vitro pharmacodynamic studies. Antimicrob Agents Chemother 1997;41:1926-32.
27. Dowell SF, Marcy SM, Phillips WR, Gerber MA, Schwartz B. Otitis media: principles of judicious use of antimicrobial agents. Pediatrics 1998;101:165-71.
28. Kozyrskyi AL, Hildes-Ripstein GE, Longstaffe SEA, et al. Treatment of acute otitis media with a shortened course of antibiotics: a meta-analysis. JAMA 1998;279:1736-42.
29. Dowell SF, Whitney CG, Schwartz B. Regional characteristics of drug-resistant respiratory pathogens. Am J Med (Continuing Educ Ser) 1997;2:9-16.
30. Zenni MK, Cheatham SH, Thompson JM, et al. Streptococcus pneumoniae colonization in the young child: association with otitis media and resistance to penicillin. J Pediatr 1995;127: 533-7.
31. Nava JM, Bella F, Garau J, et al. Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study. Clin Infect Dis 1994; 19:884-90.
32. Reichler MR, Allphin AA, Breiman RF, et al. The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio. J Infect Dis 1992;166:1346-53.
33. McCracken GH Jr. Treatment of acute otitis media in an era of increasing microbial resistance. Pediatr Infect Dis J 1998; 17:576-9.
34. Radetsky MS, Istre GR, Johansen TL, et al. Multiply resistant pneumococcus causing meningitis: its epidemiology within a day-care centre. Lancet 1981;2:771-3.
35. Robins-Browne RM, Kharsany ABM, Koornhof HJ. Antibiotic-resistant pneumococci in hospitalized children. J Hyg (Lond) 1984;93:9-16.
36. Duchin JS, Breiman RF, Diamond A, et al. High prevalence of multidrug-resistant Streptococcus pneumoniae among children in a rural Kentucky community. Pediatr Infect Dis J 1995;14:745-50.
37. Jackson MA, Shelton S, Nelson JD, McCracken GH Jr. Relatively penicillin-resistant pneumococcal infections in pediatric patients. Pediatr Infect Dis J 1984;3:129-32.
38. Pallares R, Gudiol F, Linares J, et al. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. N Engl J Med 1987;317:18-22.
39. Ford KL, Mason EO Jr, Kaplan SL, Lamberth LB, Tillman J. Factors associated with middle ear isolates of Streptococcus pneumoniae resistant to penicillin in a children's hospital. J Pediatr 1991;119:941-4.
40. Tan TQ, Mason EO Jr, Kaplan SL. Penicillin-resistant systemic pneumococcal infections in children: a retrospective case-control study. Pediatrics 1993;92:761-7.
41. Moreno F, Crisp C, Jorgensen JH, Patterson JE. The clinical and molecular epidemiology of bacteremias at a university hospital caused by pneumococci not susceptible to penicillin. J Infect Dis 1995;172:427-32.
42. Hoberman A, Paradise JL, Block S, Burch DJ, Jacobs MR, Balanescu MI. Efficacy of amoxicillin/clavulanate for acute otitis media: relation to Streptococcus pneumoniae susceptibility. Pediatr Infect Dis J 1996;15:955-62.
43. Gehanno P, Berche P, N'Guyen L, Derriennic M, Pichon F, Goehrs JM. Resolution of clinical failure in acute otitis media confirmed by in vivo bacterial eradication: efficacy and safety of ceftriaxone injected once daily, for 3 days [Abstract LM-45]. Abstracts of the 37th International Conference on Antimicrobial Agents and Chemotherapy, Toronto, September 28 to October 1, 1997. Washington, DC: American Society for Microbiology, 1997:372.
44. Leibovitz E, Piglansky L, Raiz S, et al. Bacteriologic efficacy of 3-day intramuscular ceftriaxone in nonresponsive acute otitis media [Abstract K-105]. Presented at the 37th International Conference on Antimicrobial Agents and Chemotherapy, Toronto, September 28 to October 1, 1997. Washington, DC: American Society for Microbiology, 1997:346.
45. Gudnason T, Gudbrandsson F, Barsante F, Kristianson KG. Penetration of ceftriaxone into the middle ear fluid of children. Pediatr Infect Dis J 1998;17:258-60.
46. Varsano I, Volovitz B, Horev Z, et al. Intramuscular ceftriaxone compared with oral amoxicillin-clavulanate for treatment of acute otitis media in children. Eur J Pediatr 1997;156:858-63.
47. Leibovitz E, Piglansky L, Raiz S, et al. The bacteriologic efficacy of 1-day versus 3-day intramuscular ceftriaxone in the treatment of non-responsive acute otitis media [Abstract MN-39]. Abstracts of the 38th International Conference on Antimicrobial Agents and Chemotherapy, San Diego, 1998. Washington, DC: American Society for Microbiology, 1998: 599.
48. Pichichero ME, McLinn S, Aronovitz G, et al. Cefprozil treatment of persistent and recurrent acute otitis media. Pediatr Infect Dis J 1997;16:471-8.
49. Jones RN. Ceftibuten: a review of antimicrobial activity, spectrum and other microbiologic features. Pediatr Infect Dis J 1995;14:S77-83.
50. Doern GV, Brueggemann AB, Pierce G, Holley HP Jr, Rauch A. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study. Antimicrob Agents Chemother 1997;41: 292-7.
51. Doern GV, Brueggemann AB, Pierce G, Hogan T, Holley HP Jr, Rauch A. Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: results of a 30-center national surveillance study. Antimicrob Agents Chemother 1996;40:2884-6.
52. Cetron MS, Breiman RF, Jorgensen JH, et al. Multi-site population-based surveillance for drug-resistant Streptococcus pneumoniae (DRSP) [Abstract C-283]. Abstracts of the 97th General Meeting of the American Society for Microbiology, Miami Beach, 1997. Washington, DC: American Society for Microbiology, 1997:169.
53. Ednie LM, Visalli MA, Jacobs MR, Appelbaum PC. Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci. Antimicrob Agents Chemother 1996;40: 1950-2.
54. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility tests (M 100-S8). vol. 18. Villanova, PA: National Committee for Clinical Laboratory Standards, 1998
55. Butler JC, Breiman RF, Lipman HB, Hofmann J, Facklam RR. Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978-1994: implications for development of a conjugate vaccine. J Infect Dis 1995;171:885-9.
56. Hofmann J, Cetron MS, Farley MM, et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med 1995;333:481-6.
57. Butler JC, Hofmann J, Cetron MS, Elliott JA, Facklam RR, Breiman RF. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System. J Infect Dis 1996; 174:986-93.
58. Boken DJ, Chartrand SA, Goering RV, Kruger R, Harrison CJ. Colonization with penicillin-resistant Streptococcus pneumoniae in a child-care center. Pediatr Infect Dis J 1995;14:879-84.
59. Jacobs MR, Dagan R, Appelbaum PC, Burch DJ. Prevalence of antimicrobial-resistant pathogens in middle ear fluid: multinational study of 917 children with acute otitis media. Antimicrob Agents Chemother 1998;42:589-95.